CCS Cell Culture Service GmbH, which was founded in early 2000 by the Hamburg scientist Dr. Oliver Klotzsche and his three partners, was originally dedicated to provide all kinds of cell culture related services. Within the last decade the company has advanced to one of the leading suppliers of cells and cell based reagents for pharmaceutical industries. Meanwhile CCS has 20 employees. Last year CCS launched its subsidiary at the east coast of the USA and has thereby opened a new chapter in the book of its success.

CCS Cell Culture Service has established a new technology which is now offered as a custom service to clients within drug discovery industries. By using the MaxCyte® STX™ Scalable Transfection System CCS is able to transfect batches of up to 10 billion cells in less than 30 minutes. Cell lines, primary cells and stem cells are reproducibly and efficiently transfected while maintaining the integrity of the cells for subsequent assays. As a result, bulk quantities of assay-ready frozen instant cells which are transiently expressing targets of interest can now be rapidly prepared.

CCS Cell Culture Service, an international supplier of custom generated recombinant cell lines, and custom frozen cells and membranes is very pleased to announce the opening of its Princeton, New Jersey laboratory and office space.

CCS Cell Culture Service has named Richard Field as Chief Operating Officer, North America. Mr. Field is leading the North American operations and corporate development of CCS to ensure high quality sales, support, and operations for CCS’s rapidly expanding client base. “We are proud to be serving many of the leading pharmaceutical and biotechnology companies in USA and Canada, and want to maintain the highest quality products, service and support our clients have come to enjoy”, Richard Field is outlining his goal...

CCS Cell Culture Service has launched a new US subsidiary in the state of California. Since 8 years, CCS is supporting pharmaceutical companies in their drug screening campaigns. "The expansion into the US market will facilitate a closer collaboration with our American customers and let.....

CCS Cell Culture Service's Quality Management System has been recertified according to ISO 9001:2008. During the recent years CCS has steadily expanded and improved its administrative and manufacturing procedures. After the initial certification in 2003 the quality management system has now.....

Biotechnology companies CCS Cell Culture Service GmbH and Cytocentrics AG today announced the signing of a research and license agreement. The aim of the cooperation is to develop electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.....

Since the beginning of 2008 Dr. Anne Schlueter is managing the department of Molecular Biology of CCS Cell Culture Service. She is taking over the function of Dr. Christian Bauer who has left the company at the end of the year....

CCS Cell Culture Service is developing novel cell based assays, to analyze the selective effect of compounds on G protein-coupled receptors (GPCRs) in heterodimeric complexes. GPCRs constitute the largest family of membrane proteins and more than 50 percent of drugs on the market today target GPCRs.....